Table 2.
Characteristic | Hazard ratio (95% CI) | p value |
---|---|---|
Age, years | ||
|
Reference | – |
|
1.03 (0.96–1.09) | 0.448 |
|
1.02 (0.96–1.09) | 0.499 |
|
0.96 (0.89–1.02) | 0.174 |
Race | ||
|
Reference | – |
|
1.22 (1.14–1.29) | <0.001 |
Hypertension | 1.08 (1.02–1.15) | 0.014 |
Diabetes | 1.22 (1.13–1.31) | <0.001 |
Dyslipidemia | 0.88 (0.81–0.95) | 0.001 |
Cardiovascular disease | 1.77 (1.66–1.89) | <0.001 |
Hepatitis C virus | 1.33 (1.26–1.40) | <0.001 |
CD4 count, cells/mm3 | ||
|
Reference | – |
|
1.09 (0.97–1.22) | 0.135 |
|
1.29 (1.16–1.42) | <0.001 |
|
2.54 (2.33–2.77) | <0.001 |
Viral load, copies/ml | ||
|
Reference | – |
|
1.09 (0.99–1.18) | 0.077 |
|
1.55 (1.40–1.72) | <0.001 |
|
2.51 (2.28–2.75) | <0.001 |
Body mass index | ||
|
1.69 (1.54–1.86) | <0.001 |
|
Reference | – |
|
0.82 (0.77–0.88) | <0.001 |
Albumin, mg/dl | ||
|
Reference | – |
|
1.30 (1.17–1.44) | <0.001 |
|
1.75 (1.59–1.94) | <0.001 |
|
5.24 (4.82–5.71) | <0.001 |
eGFR <60 ml/min/1.73 m2 | 5.38 (5.11–5.67) | <0.001 |
Proteinuria | 1.78 (1.70–1.87) | <0.001 |
Multivariate model includes factors with a p value <0.05 in univariate analysis. All factors in table 1 were evaluated as candidate predictors. All estimates are adjusted for receipt of antiretroviral therapy.